Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (531-540 of 6,828) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|May 10, 2023
GSK buys purine receptor antagonist for $2 billionAsher Mullard
Nature Reviews. Drug Discovery|May 10, 2023
Astellas buys complement inhibitor for $5.9 billionAsher Mullard
Nature Reviews. Drug Discovery|April 17, 2021
RECOVERY 1 year on: a rare success in the COVID-19 clinical trial landscapeAsher Mullard
Adler Museum Bulletin|March 24, 2010
Women in medicine: Maude Abbott (1869-1940)Asher Dubb
Nature Reviews. Drug Discovery|October 2, 2012
Economists propose a US$30 billion boost to biomedical R&DAsher Mullard
Nature Reviews. Drug Discovery|December 6, 2023
A decade of HCV drugsAsher Mullard
Nature Reviews. Drug Discovery|January 3, 2024
2023 FDA approvalsAsher Mullard
Nature Reviews. Drug Discovery|November 6, 2012
Cholesterol-lowering blockbuster candidates speed into Phase III trialsAsher Mullard
Nature Reviews. Drug Discovery|January 15, 2024
Radiopharmaceuticals garner continued M&A investmentsAsher Mullard
Nature Reviews. Drug Discovery|October 14, 2024
Protein degraders push into novel target spaceAsher Mullard
Pageof 683

Showing results (531-540 of 6,828) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|May 10, 2023
GSK buys purine receptor antagonist for $2 billionAsher Mullard
Nature Reviews. Drug Discovery|May 10, 2023
Astellas buys complement inhibitor for $5.9 billionAsher Mullard
Nature Reviews. Drug Discovery|April 17, 2021
RECOVERY 1 year on: a rare success in the COVID-19 clinical trial landscapeAsher Mullard
Adler Museum Bulletin|March 24, 2010
Women in medicine: Maude Abbott (1869-1940)Asher Dubb
Nature Reviews. Drug Discovery|October 2, 2012
Economists propose a US$30 billion boost to biomedical R&DAsher Mullard
Nature Reviews. Drug Discovery|December 6, 2023
A decade of HCV drugsAsher Mullard
Nature Reviews. Drug Discovery|January 3, 2024
2023 FDA approvalsAsher Mullard
Nature Reviews. Drug Discovery|November 6, 2012
Cholesterol-lowering blockbuster candidates speed into Phase III trialsAsher Mullard
Nature Reviews. Drug Discovery|January 15, 2024
Radiopharmaceuticals garner continued M&A investmentsAsher Mullard
Nature Reviews. Drug Discovery|October 14, 2024
Protein degraders push into novel target spaceAsher Mullard
Pageof 683